Cargando…
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
Cancer cells acquire essential characteristics for metastatic dissemination through the process of epithelial-to-mesenchymal transition (EMT), which is regulated by gene expression and chromatin remodeling changes. The enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the polycomb repress...
Autores principales: | Cardenas, Horacio, Zhao, Janice, Vieth, Edyta, Nephew, Kenneth P., Matei, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356672/ https://www.ncbi.nlm.nih.gov/pubmed/27563817 http://dx.doi.org/10.18632/oncotarget.11497 |
Ejemplares similares
-
Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells
por: Ji, Liang, et al.
Publicado: (2018) -
RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis
por: Huang, Yuting, et al.
Publicado: (2014) -
Ovarian Cancer—Why Lipids Matter
por: Zhao, Guangyuan, et al.
Publicado: (2019) -
NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017) -
Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)